This guidance finalizes the draft guidance of the same title dated January 2020, and supersedes the document entitled “Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2OcZ8bd
No comments:
Post a Comment